Oxeltis is a medchem services company with hit to lead optimization services in various therapeutic fields. Oxeltis’ scientific team has a recognized expertise in specific areas of organic synthesis: heterocycles, macrocycles, nucleosides/nucleotides, phosphoramidites, modified sugars, oligo/polysaccharides, and PROTAC. Oxeltis has completed over 35 projects and several drug candidates delivered to its customers are in clinical development. Oxeltis works in EU, Japan, and North America.
December 15th, 2023